Details for Patent: 10,996,208
✉ Email this page to a colleague
Which drugs does patent 10,996,208 protect, and when does it expire?
Patent 10,996,208 protects TYMLOS and is included in one NDA.
Summary for Patent: 10,996,208
| Title: | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
| Abstract: | Provided herein are newly discovered methods of analyzing abaloparatide samples for abaloparatide isomers. Additionally, methods of storing and treating with abaloparatide in view of the newly discovered abaloparatide isomers are described. |
| Inventor(s): | Williams; Greg (Parsippany, NJ), Palwai; Naveen (Parsippany, NJ), Hanley; David (Parsippany, NJ) |
| Assignee: | Radius Health, Inc. (Waltham, MA) |
| Application Number: | 16/553,889 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,996,208
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radius | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
